Phase 2 Trial of Acalabrutinib-Lenalidomide-Rituximab (ALR) with Real-Time Monitoring of MRD in Patients with Treatment-Naïve Mantle Cell Lymphoma
| Autor: | Ruan, Jia, Leonard, John P., Chen, Gui Zhen *, Chen, Zhengming *, Allan, John N., Rutherford, Sarah C., Hobbie, Brittany *, Greig, Katie *, Rodriguez, Amelyn *, Tam, Wayne, Bond, David A., Shah, Bijal D., Maddocks, Kami J., Binder, Bhavneet *, Inghirami, Giorgio *, Elemento, Olivier *, Chen-Kiang, Selina, Martin, Peter |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:175-177 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|